We're delighted to welcome Professor Srinivasan Madhusudan who joins us as Cancer Lead for the East Midlands.
Prof Madhusudan is an Oncology Consultant at Nottingham University Hospitals (NUH) NHS Trust and a Professor of Medical Oncology at the University of Nottingham.
He served as the Head of Oncology at NUH from 2017-2020. As an academic oncologist, he is very active in cancer clinical trials. He has led the Cancer Clinical Trials Unit at NUH and was previously the National Institute for Health Research (NIHR) Divisional Lead for Cancer (East Midlands).
His Clinical Research expertise is in breast, upper GI and ovarian cancers. His pre-clinical laboratory research is focused on the evaluation of DNA damage signaling and repair in cancer. He is the Director of the Nottingham Ovarian Cancer Research Centre (NOVARC) based at the Biodiscovery Institute. He is an active member of the Nottingham Breast Cancer Research Centre (NBCRC). Research in his laboratory has received funding from the Medical Research Council, Breast Cancer Now, Target Ovarian Cancer and Naaz-Coker Ovarian Cancer Research Fellowship.
Prof Madhusudan's group has identified novel biomarkers, potential drug targets and newer approaches for personalized treatment strategies targeting DNA repair in cancer. Prof Madhusudan has published over 150 research articles, edited two books and contributed to several book chapters. In recognition of his outstanding translational cancer research, he was recently awarded the prestigious 'Lady Estelle Wolfson lectureship in Translational Medicine for 2019' by the Royal College of Physicians of London.
Watch our short vieo introduction to Prof Madhusudan and his reflections on his new role as our Cancer Lead for the East Midlands
Link: https://youtu.be/x3ou--p3ee0?si=VXxQjcE0HDNJq1al
